The SARS-CoV-2 that causes theCOVID-19 disease is a one-in-a-century disaster that has led to profound structural change in every conceivable aspect of the worldwide community. The COVID-19 pandemic is the most topical subject in the academic community across all disciplines, but especially in the medical and biomedical research disciplines, where attempts to discover a safe, effective, timely, inexpensive, and accessible vaccine is at the top of everyone's wish list. There is a substantial amount of confusion, ambiguity, and misinformation in the academic community, and far more so in social mass media. Leading medical journals, such as the Journal of the American Medical Association (JAMA), The Lancet, and the New England Journal of Medicine, have published informative case studies that seek to provide guidance on COVID-19 at the earliest possible opportunity.

Additional Metadata
Keywords Business, economics and finance, COVID-19, Healthcare facilities, medical research, Masking, Opening up society and the economy, Public policy pronouncements, SARS-CoV-2
JEL Criteria for Decision-Making under Risk and Uncertainty (jel D81), Financing Policy; Capital and Ownership Structure (jel G32), Crisis Management (jel H12), Entertainment; Media (Performing Arts, Visual Arts, Broadcasting, Publishing, etc.) (jel L82)
Persistent URL hdl.handle.net/1765/130382
Journal Advances in Decision Sciences
Citation
McAleer, M.J. (2020). Comments on recent COVID-19 research in JAMA. Advances in Decision Sciences, 24(3), 1–20. Retrieved from http://hdl.handle.net/1765/130382